[HTML][HTML] Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis

Y Zhou, Q Yang, J Chi, B Dong, W Lv, L Shen… - International Journal of …, 2020 - Elsevier
Objectives Existing findings regarding the relationship between comorbidities and the
severity of coronavirus disease 2019 (COVID-19) are inconsistent and insufficient. The aim …

Comorbidities' potential impacts on severe and non-severe patients with COVID-19: A systematic review and meta-analysis

S Cheng, Y Zhao, F Wang, Y Chen, AC Kaminga, H Xu - Medicine, 2021 - journals.lww.com
Background: An ongoing outbreak of pneumonia associated with the severe acute
respiratory coronavirus (SARS-CoV-2) emerged in December 2019 in Wuhan, China …

Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors

T Yin, Y Li, Y Ying, Z Luo - BMC infectious diseases, 2021 - Springer
Abstract Background Coronavirus disease 2019 (COVID-19) is an infectious disease
characterized by cough, fever, and fatigue and 20% of cases will develop into severe …

A systematic review and meta-analysis of geographic differences in comorbidities and associated severity and mortality among individuals with COVID-19

B Thakur, P Dubey, J Benitez, JP Torres, S Reddy… - Scientific reports, 2021 - nature.com
Several comorbidities have been shown to be associated with coronavirus disease 2019
(COVID-19) related severity and mortality. However, considerable variation in the …

[HTML][HTML] Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis

B Wang, R Li, Z Lu, Y Huang - Aging (albany NY), 2020 - ncbi.nlm.nih.gov
Currently, the number of patients with coronavirus disease 2019 (COVID-19) has increased
rapidly, but relationship between comorbidity and patients with COVID-19 still not clear. The …

[HTML][HTML] Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis

J Yang, YA Zheng, X Gou, K Pu, Z Chen, Q Guo… - International journal of …, 2020 - Elsevier
Background An outbreak of coronavirus disease 2019 (COVID-19) occurred in Wuhan,
China; the epidemic is more widespread than initially estimated, with cases now confirmed …

The epidemiological burden and overall distribution of chronic comorbidities in coronavirus disease-2019 among 202,005 infected patients: evidence from a …

RA Mahumud, JK Kamara, AMN Renzaho - Infection, 2020 - Springer
Purpose The main purpose of this study was to examine the overall distribution of chronic
comorbidities in coronavirus disease-19 (COVID-19) infected populations and the risk of the …

COVID-19 and comorbidities: a systematic review and meta-analysis

MS Gold, D Sehayek, S Gabrielli, X Zhang… - Postgraduate …, 2020 - Taylor & Francis
ABSTRACT SARS-CoV-2 has caused a worldwide pandemic that began with an outbreak of
pneumonia cases in the Hubei province of China. Knowledge of those most at risk is integral …

Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients

ZG Dessie, T Zewotir - BMC infectious diseases, 2021 - Springer
Background Mortality rates of coronavirus disease-2019 (COVID-19) continue to rise across
the world. The impact of several risk factors on coronavirus mortality has been previously …

Predictors of mortality in patients with coronavirus disease 2019: a systematic review and meta-analysis

C Shi, L Wang, J Ye, Z Gu, S Wang, J Xia, Y Xie… - BMC infectious …, 2021 - Springer
Abstract Background Coronavirus disease 2019 (COVID-19) is associated with a high
mortality rate, especially in patients with severe illness. We conducted a systematic review …